Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleThe FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
- Where
- Washington D.C.
- Age
- 18 years to 74 years
- People
- 80
- Run by
- Georgetown University
See details and how to joinNCT06892275 - Phase 1/2Taking peopleA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Where
- Ann Arbor, Boston, Dallas, Houston, Los Angeles, Nashville
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT05941507 - No phaseTaking peopleGonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
- Where
- Aurora
- Age
- Up to 30 years
- People
- 50
- Run by
- University of Colorado, Denver
See details and how to joinNCT06518746 - No phaseTaking peopleDeveloping a Test of Uterine Lavage for the Detection of Ovarian Cancer
- Where
- Annapolis, Baltimore, Boston, Little Rock, San Francisco, Seattle
- Age
- 30 years and over
- People
- 250
- Run by
- Massachusetts General Hospital
See details and how to joinNCT04794322 - Phase 1Taking peopleA Study of NX-1607 in Adults With Advanced Malignancies
- Where
- Aurora, Chapel Hill, Charlottesville, Chicago, Duarte, Houston, Los Angeles, Oklahoma City, San Francisco, Seattle
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05107674 - Phase 2Taking peopleInvestigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
- Where
- Oklahoma City, Seattle
- Age
- 18 years and over
- People
- 40
- Run by
- Allarity Therapeutics
See details and how to joinNCT03878849 - Phase 2Taking peopleRegorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
- Where
- Cleveland
- Age
- 18 years and over
- People
- 31
- Run by
- Sarah K. Lynam MD
See details and how to joinNCT05113368 - Phase 1/2Taking peopleA Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- Where
- Baltimore, Houston, Los Angeles, Nashville
- Age
- 18 years and over
- People
- 122
- Run by
- AtlasMedx, Incorporated
See details and how to joinNCT04503265 - Early phase 1Not yet taking people in United StatesLipid Mediators & Cancer: Montelukast, SPM, and Almonds
- Where
- Tampa
- Age
- 18 years and over
- People
- 56
- Run by
- University of South Florida
See details and how to joinNCT06887673 - Phase 1Taking peopleBP1001-A in Patients With Advanced or Recurrent Solid Tumors
- Where
- Dallas, Detroit, Houston, Silver Spring
- Age
- 18 years and over
- People
- 50
- Run by
- Bio-Path Holdings, Inc.
See details and how to joinNCT04196257 - No phaseTaking peopleNYSCF Scientific Discovery Biobank
- Where
- New York
- Age
- 30 days and over
- People
- 10,000
- Run by
- New York Stem Cell Foundation Research Institute
See details and how to joinNCT06203106 - No phaseTaking peopleSpecimen and Data Study for Ovarian Cancer Early Detection and Prevention
- Where
- Chicago
- Age
- 18 years to 80 years
- People
- 6,000
- Run by
- Northwestern University
See details and how to joinNCT00005095 - No phaseTaking peopleDysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
- Where
- Knoxville
- Age
- 18 years and over
- People
- 10
- Run by
- University of Tennessee Graduate School of Medicine
See details and how to joinNCT06800105 - No phaseTaking peopleClinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 15,000
- Run by
- MiraKind
See details and how to joinNCT02253251 - Phase 1Not yet taking people in United StatesEPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
- Where
- Seattle
- Age
- 18 years and over
- People
- 55 worldwide
- Run by
- Medigene AG
See details and how to joinNCT06748872 · EU 2024-516787-28-00 - No phaseTaking peopleComprehensive Outcomes for After Cancer Health
- Where
- Boston, Columbus, Gainesville, Houston, New York, Omaha
- Age
- 18 years and over
- People
- 625
- Run by
- Pack Health
See details and how to joinNCT05349227 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Where
- Cleveland, Jacksonville, New York, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT05824975 - Phase 1/2Not yet taking people in United StatesBMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer
- Where
- Durham
- Age
- 18 years and over
- People
- 27
- Run by
- BioMimetix JV, LLC
See details and how to joinNCT06620029 - No phaseNot yet taking people in United StatesFasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer
- Where
- Evanston
- Age
- 18 years and over
- People
- 170
- Run by
- Endeavor Health
See details and how to joinNCT05921149 - Phase 2Taking peopleDecitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
- Where
- Maywood
- Age
- 18 years and over
- People
- 40
- Run by
- Loyola University
See details and how to joinNCT05983276 - Phase 1Taking peopleA First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
- Where
- Dallas, Fairfax
- Age
- 18 years and over
- People
- 38
- Run by
- Hefei TG ImmunoPharma Co., Ltd.
See details and how to joinNCT05746897 - Phase 2Taking peopleCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Where
- Chicago
- Age
- 18 years and over
- People
- 94
- Run by
- Northwestern University
See details and how to joinNCT05733000 - No phaseTaking peopleStudy of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- Where
- Philadelphia
- People
- 174
- Run by
- Gynecologic Oncology Group
See details and how to joinNCT01000259